{"id":8547,"date":"2022-12-08T19:14:04","date_gmt":"2022-12-09T00:14:04","guid":{"rendered":"https:\/\/www.bluerocktx.com\/?p=8547"},"modified":"2024-01-23T13:16:40","modified_gmt":"2024-01-23T18:16:40","slug":"the-future-of-ipscs-with-bluerock-therapeutics-ceo-seth-ettenberg","status":"publish","type":"post","link":"https:\/\/www.bluerocktx.com\/the-future-of-ipscs-with-bluerock-therapeutics-ceo-seth-ettenberg\/","title":{"rendered":"The Cell and Gene Podcast: The Future Of iPSCs With BlueRock Therapeutics&#8217; CEO Seth Ettenberg"},"content":{"rendered":"<p>BlueRock Therapeutics&#8217; President and CEO Seth Ettenberg, Ph.D. talks to Cell &amp; Gene: The Podcast listeners about the company&#8217;s Phase 1 Clinical Trial for Advanced Parkinson\u2019s Disease. Ettenberg also covers the most promising therapeutic applications for iPSCs currently in development as well as the major regulatory challenges that the field faces for their clinical use. We also cover how far iPSCs have come and what future progress may entail.<\/p>\n<p><a href=\"https:\/\/www.cellandgene.com\/doc\/the-future-of-ipscs-with-bluerock-therapeutics-ceo-seth-ettenberg-0001\" target=\"_blank\" rel=\"noopener\"><strong>Click Here To Listen<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>BlueRock Therapeutics&#8217; President and CEO Seth Ettenberg, Ph.D. talks to Cell &amp; Gene: The Podcast listeners about the company&#8217;s Phase 1 Clinical Trial for Advanced Parkinson\u2019s Disease. Ettenberg also covers the most promising therapeutic applications for iPSCs currently in development as well as the [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":8549,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[59],"tags":[57,61,62,74,77,78,81],"class_list":["post-8547","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-podcasts","tag-clinical-trials","tag-parkinsons-disease","tag-podcast","tag-cell-therapy","tag-cell-and-gene","tag-ipscs","tag-leadership"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>The Cell and Gene Podcast: The Future Of iPSCs With BlueRock Therapeutics&#039; CEO Seth Ettenberg - BlueRock Therapeutics LP<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.bluerocktx.com\/the-future-of-ipscs-with-bluerock-therapeutics-ceo-seth-ettenberg\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Cell and Gene Podcast: The Future Of iPSCs With BlueRock Therapeutics&#039; CEO Seth Ettenberg - BlueRock Therapeutics LP\" \/>\n<meta property=\"og:description\" content=\"BlueRock Therapeutics&#8217; President and CEO Seth Ettenberg, Ph.D. talks to Cell &amp; Gene: The Podcast listeners about the company&#8217;s Phase 1 Clinical Trial for Advanced Parkinson\u2019s Disease. Ettenberg also covers the most promising therapeutic applications for iPSCs currently in development as well as the [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.bluerocktx.com\/the-future-of-ipscs-with-bluerock-therapeutics-ceo-seth-ettenberg\/\" \/>\n<meta property=\"og:site_name\" content=\"BlueRock Therapeutics LP\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-09T00:14:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-01-23T18:16:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.bluerocktx.com\/wp-content\/uploads\/2023\/12\/sddefault.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"480\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"BlueRock Therapeutics\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"BlueRock Therapeutics\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.bluerocktx.com\/the-future-of-ipscs-with-bluerock-therapeutics-ceo-seth-ettenberg\/\",\"url\":\"https:\/\/www.bluerocktx.com\/the-future-of-ipscs-with-bluerock-therapeutics-ceo-seth-ettenberg\/\",\"name\":\"The Cell and Gene Podcast: The Future Of iPSCs With BlueRock Therapeutics' CEO Seth Ettenberg - BlueRock Therapeutics LP\",\"isPartOf\":{\"@id\":\"https:\/\/www.bluerocktx.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.bluerocktx.com\/the-future-of-ipscs-with-bluerock-therapeutics-ceo-seth-ettenberg\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.bluerocktx.com\/the-future-of-ipscs-with-bluerock-therapeutics-ceo-seth-ettenberg\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.bluerocktx.com\/wp-content\/uploads\/2023\/12\/sddefault.jpg\",\"datePublished\":\"2022-12-09T00:14:04+00:00\",\"dateModified\":\"2024-01-23T18:16:40+00:00\",\"author\":{\"@id\":\"https:\/\/www.bluerocktx.com\/#\/schema\/person\/7bce67a9ee8dcf888329288a28761057\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.bluerocktx.com\/the-future-of-ipscs-with-bluerock-therapeutics-ceo-seth-ettenberg\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.bluerocktx.com\/the-future-of-ipscs-with-bluerock-therapeutics-ceo-seth-ettenberg\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.bluerocktx.com\/the-future-of-ipscs-with-bluerock-therapeutics-ceo-seth-ettenberg\/#primaryimage\",\"url\":\"https:\/\/www.bluerocktx.com\/wp-content\/uploads\/2023\/12\/sddefault.jpg\",\"contentUrl\":\"https:\/\/www.bluerocktx.com\/wp-content\/uploads\/2023\/12\/sddefault.jpg\",\"width\":640,\"height\":480},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.bluerocktx.com\/the-future-of-ipscs-with-bluerock-therapeutics-ceo-seth-ettenberg\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.bluerocktx.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Cell and Gene Podcast: The Future Of iPSCs With BlueRock Therapeutics&#8217; CEO Seth Ettenberg\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.bluerocktx.com\/#website\",\"url\":\"https:\/\/www.bluerocktx.com\/\",\"name\":\"BlueRock Therapeutics LP\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.bluerocktx.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.bluerocktx.com\/#\/schema\/person\/7bce67a9ee8dcf888329288a28761057\",\"name\":\"BlueRock Therapeutics\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.bluerocktx.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/154b53ac9f1feafa6f14d0efa17a4fdb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/154b53ac9f1feafa6f14d0efa17a4fdb?s=96&d=mm&r=g\",\"caption\":\"BlueRock Therapeutics\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The Cell and Gene Podcast: The Future Of iPSCs With BlueRock Therapeutics' CEO Seth Ettenberg - BlueRock Therapeutics LP","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.bluerocktx.com\/the-future-of-ipscs-with-bluerock-therapeutics-ceo-seth-ettenberg\/","og_locale":"en_US","og_type":"article","og_title":"The Cell and Gene Podcast: The Future Of iPSCs With BlueRock Therapeutics' CEO Seth Ettenberg - BlueRock Therapeutics LP","og_description":"BlueRock Therapeutics&#8217; President and CEO Seth Ettenberg, Ph.D. talks to Cell &amp; Gene: The Podcast listeners about the company&#8217;s Phase 1 Clinical Trial for Advanced Parkinson\u2019s Disease. Ettenberg also covers the most promising therapeutic applications for iPSCs currently in development as well as the [&hellip;]","og_url":"https:\/\/www.bluerocktx.com\/the-future-of-ipscs-with-bluerock-therapeutics-ceo-seth-ettenberg\/","og_site_name":"BlueRock Therapeutics LP","article_published_time":"2022-12-09T00:14:04+00:00","article_modified_time":"2024-01-23T18:16:40+00:00","og_image":[{"width":640,"height":480,"url":"https:\/\/www.bluerocktx.com\/wp-content\/uploads\/2023\/12\/sddefault.jpg","type":"image\/jpeg"}],"author":"BlueRock Therapeutics","twitter_card":"summary_large_image","twitter_misc":{"Written by":"BlueRock Therapeutics","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.bluerocktx.com\/the-future-of-ipscs-with-bluerock-therapeutics-ceo-seth-ettenberg\/","url":"https:\/\/www.bluerocktx.com\/the-future-of-ipscs-with-bluerock-therapeutics-ceo-seth-ettenberg\/","name":"The Cell and Gene Podcast: The Future Of iPSCs With BlueRock Therapeutics' CEO Seth Ettenberg - BlueRock Therapeutics LP","isPartOf":{"@id":"https:\/\/www.bluerocktx.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.bluerocktx.com\/the-future-of-ipscs-with-bluerock-therapeutics-ceo-seth-ettenberg\/#primaryimage"},"image":{"@id":"https:\/\/www.bluerocktx.com\/the-future-of-ipscs-with-bluerock-therapeutics-ceo-seth-ettenberg\/#primaryimage"},"thumbnailUrl":"https:\/\/www.bluerocktx.com\/wp-content\/uploads\/2023\/12\/sddefault.jpg","datePublished":"2022-12-09T00:14:04+00:00","dateModified":"2024-01-23T18:16:40+00:00","author":{"@id":"https:\/\/www.bluerocktx.com\/#\/schema\/person\/7bce67a9ee8dcf888329288a28761057"},"breadcrumb":{"@id":"https:\/\/www.bluerocktx.com\/the-future-of-ipscs-with-bluerock-therapeutics-ceo-seth-ettenberg\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.bluerocktx.com\/the-future-of-ipscs-with-bluerock-therapeutics-ceo-seth-ettenberg\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.bluerocktx.com\/the-future-of-ipscs-with-bluerock-therapeutics-ceo-seth-ettenberg\/#primaryimage","url":"https:\/\/www.bluerocktx.com\/wp-content\/uploads\/2023\/12\/sddefault.jpg","contentUrl":"https:\/\/www.bluerocktx.com\/wp-content\/uploads\/2023\/12\/sddefault.jpg","width":640,"height":480},{"@type":"BreadcrumbList","@id":"https:\/\/www.bluerocktx.com\/the-future-of-ipscs-with-bluerock-therapeutics-ceo-seth-ettenberg\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.bluerocktx.com\/"},{"@type":"ListItem","position":2,"name":"The Cell and Gene Podcast: The Future Of iPSCs With BlueRock Therapeutics&#8217; CEO Seth Ettenberg"}]},{"@type":"WebSite","@id":"https:\/\/www.bluerocktx.com\/#website","url":"https:\/\/www.bluerocktx.com\/","name":"BlueRock Therapeutics LP","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.bluerocktx.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.bluerocktx.com\/#\/schema\/person\/7bce67a9ee8dcf888329288a28761057","name":"BlueRock Therapeutics","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.bluerocktx.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/154b53ac9f1feafa6f14d0efa17a4fdb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/154b53ac9f1feafa6f14d0efa17a4fdb?s=96&d=mm&r=g","caption":"BlueRock Therapeutics"}}]}},"_links":{"self":[{"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/posts\/8547"}],"collection":[{"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/comments?post=8547"}],"version-history":[{"count":2,"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/posts\/8547\/revisions"}],"predecessor-version":[{"id":8554,"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/posts\/8547\/revisions\/8554"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/media\/8549"}],"wp:attachment":[{"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/media?parent=8547"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/categories?post=8547"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/tags?post=8547"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}